<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="9505">Nitroblue tetrazolium</z:chebi> (<z:chebi fb="8" ids="9505">NBT</z:chebi>) is reduced to a blue dye (blue formazan, gamma max 560 nm) by <z:chebi fb="1" ids="18421">superoxide</z:chebi> (<z:chebi fb="38" ids="18421,29356">O2-</z:chebi>.) released from phagocytes upon <z:chebi fb="0" ids="8116">phorbol</z:chebi> <z:chebi fb="0" ids="30807">myristate</z:chebi> <z:chebi fb="49" ids="30089,47622">acetate</z:chebi>-stimulation, resulting in the blue dye-deposition on the cell membrane </plain></SENT>
<SENT sid="1" pm="."><plain>Thus, we tried to develop a semi-quantification method for determining the <z:chebi fb="8" ids="9505">NBT</z:chebi>-reducing activity in the peripheral leukocytes (<z:chebi fb="8" ids="9505">NBT</z:chebi>-staining intensity -SI- and its distribution in the cell) by flow cytometry </plain></SENT>
<SENT sid="2" pm="."><plain>The SI (mean +/- SD) was 28.4 +/- 2.2 (n = 30) in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects and 0.9 in a patient with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0740451" disease_type="Disease or Syndrome" abbrv="">granulomatous disease</z:e>, whereas it was 37.6 in a patient with <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> showed values of 29.2 +/- 7.0 (n = 11), while a patient with partial <z:mp ids='MP_0004026'>monosomy</z:mp> of chromosome No. 7 had an SI of 10.8 </plain></SENT>
<SENT sid="4" pm="."><plain>The present assay of <z:chebi fb="8" ids="9505">NBT</z:chebi>-reducing activity in phagocytes may be useful for screening of peripheral leukocyte function </plain></SENT>
</text></document>